Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells

G Lake-Bakaar1, V Mazzoccoli, K Dickman

  • 1Department of Medicine, VAMC, Northport, New York 11768, USA.

Insights

Nucleoside analogs damage mitochondrial DNA, but dideoxyinosine (ddI) and dideoxyadenosine (ddA) cause less cell toxicity than dideoxycytosine (ddC) and didehydrodeoxythymidine (d4T) in human pancreatic cells.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Nucleoside analogs are used to inhibit viral replication.
  • Different analogs exhibit organ-specific toxicities, such as pancreatitis with ddI and neuropathy with ddC.
  • Understanding differential mitochondrial toxicity mechanisms is crucial for drug development.

Purpose of the Study:

  • To compare the effects of various nucleoside analogs on mitochondrial function in a human pancreatic cell line (Capan-1).
  • To investigate the mechanisms underlying the differential organ toxicities of nucleoside analogs.

Main Methods:

  • Treatment of Capan-1 cells with dideoxyinosine (ddI), dideoxyadenosine (ddA), dideoxycytosine (ddC), Azidothymidine (AZT), and didehydrodeoxythymidine (d4T).
  • Assays for mtDNA elongation, cytotoxicity, oxidative phosphorylation, cellular ATP concentration, and lactate production.
  • Electron microscopy to examine mitochondrial ultrastructure.

Main Results:

  • All tested analogs, except AZT, increased lactate concentration.
  • ddI and ddA reduced oxygen consumption, while ddC and d4T did not significantly affect it.
  • ddC and d4T showed greater cytotoxicity than ddI and ddA, despite similar ATP levels in surviving cells.
  • Electron microscopy revealed ultrastructural damage to mitochondria with ddI treatment.

Conclusions:

  • Nucleoside analogs uniformly damage mitochondrial DNA.
  • Mitochondrial damage from ddI and ddA leads to less cytotoxicity in Capan-1 cells compared to ddC and d4T.
  • The precise link between these differential mitochondrial effects and clinical organ toxicities remains unclear.